Magenta Therapeutics (MGTA) Desperately Considers All Its Options
Magenta Therapeutics Inc. (NASDAQ: MGTA) is facing a lethal uphill battle in its fight for survival. This biopharma company saw its prospects flatten after dismal
Magenta Therapeutics Inc. (NASDAQ: MGTA) is facing a lethal uphill battle in its fight for survival. This biopharma company saw its prospects flatten after dismal
Genetic Technologies Ltd. (NASDAQ: GENE) is a promising Australian biotech player that has made remarkable strides in the realm of genetic testing and risk identification.
ReShape Life Sciences Inc. (NASDAQ: RSLS) is a company specializing in medical equipment that is geared towards patients suffering from heart conditions and obesity to
Motorsport Games Inc. (NASDAQ: MSGM) is a US-based gaming company that develops racing games for customers. It is a small company that has been off
Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) is a pharma player with a focus on the rare disease segment. Its treatment for Netherton syndrome has been gaining
The Metals Company Inc. (NASDAQ: TMC) is a deep-sea miner that has been playing all its cards right. 2022 proved to be a stellar year
TransCode Therapeutics Inc. (NASDAQ: RNAZ) is a promising biotech company that has been in and out of the market spotlight in recent weeks and months.
Applied Therapeutics Inc. (NASDAQ: APLT) is a biotech company with a focus on galactosemia, diabetes, and cardiovascular conditions. Its lead candidate is AT-007 which will
GeoVax Labs Inc. (NASDAQ: GOVX) is a biotechnology company that specializes in developing and commercializing treatments for various cancers and viral conditions. Many describe GeoVax
COMSovereign Holding Corp. (NASDAQ: COMS) is a telecom solutions company offering next-gen technological tools to mobile device carriers, network operators, enterprises, and government agencies. Its
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.